Kestra Private Wealth Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.95M | Buy |
27,897
+2,857
| +11% | +$200K | 0.03% | 509 |
|
2025
Q1 | $1.84M | Buy |
25,040
+9,595
| +62% | +$705K | 0.03% | 476 |
|
2024
Q4 | $1.01M | Sell |
15,445
-1,644
| -10% | -$108K | 0.02% | 646 |
|
2024
Q3 | $1.33M | Sell |
17,089
-728
| -4% | -$56.7K | 0.02% | 526 |
|
2024
Q2 | $1.39M | Buy |
17,817
+894
| +5% | +$69.7K | 0.03% | 484 |
|
2024
Q1 | $1.15M | Sell |
16,923
-415
| -2% | -$28.1K | 0.03% | 521 |
|
2023
Q4 | $1.17M | Buy |
17,338
+648
| +4% | +$43.6K | 0.03% | 485 |
|
2023
Q3 | $1.13M | Sell |
16,690
-294
| -2% | -$19.9K | 0.04% | 425 |
|
2023
Q2 | $1.22M | Buy |
16,984
+6,090
| +56% | +$436K | 0.04% | 397 |
|
2023
Q1 | $756K | Buy |
10,894
+67
| +0.6% | +$4.65K | 0.03% | 489 |
|
2022
Q4 | $734K | Sell |
10,827
-3,543
| -25% | -$240K | 0.04% | 431 |
|
2022
Q3 | $788K | Sell |
14,370
-943
| -6% | -$51.7K | 0.05% | 380 |
|
2022
Q2 | $1.01M | Sell |
15,313
-185
| -1% | -$12.2K | 0.06% | 348 |
|
2022
Q1 | $1.03M | Sell |
15,498
-2,558
| -14% | -$170K | 0.05% | 373 |
|
2021
Q4 | $1.05M | Sell |
18,056
-816
| -4% | -$47.5K | 0.05% | 373 |
|
2021
Q3 | $1.13M | Buy |
18,872
+3,404
| +22% | +$204K | 0.06% | 322 |
|
2021
Q2 | $927K | Buy |
15,468
+1,646
| +12% | +$98.6K | 0.06% | 345 |
|
2021
Q1 | $687K | Buy |
13,822
+2,692
| +24% | +$134K | 0.05% | 384 |
|
2020
Q4 | $559K | Sell |
11,130
-1,214
| -10% | -$61K | 0.04% | 416 |
|
2020
Q3 | $676K | Buy |
+12,344
| New | +$676K | 0.06% | 323 |
|